Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis

The unprecedented successes of immunotherapies (IOs) including immune checkpoint blockers (ICBs) and adoptive T-cell therapy (ACT) in patients with late-stage cancer provide proof-of-principle evidence that harnessing the immune system, in particular T cells, can be an effective approach to eradicat...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lewis Zhichang Shi, James A. Bonner
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
JAK
Accès en ligne:https://doaj.org/article/186df8d319744d2c830cfb34d6ea2a78
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!